{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-025530","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2022-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.670003+00:00","generated_at":"2026-06-21T14:56:36.316866+00:00","sec_items":["1.01","1.02","2.03","3.02","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Biodesix raises $70.7M via $50M term loan and $40.3M equity; retires $24M in debt","bullets":["Entered $50M Perceptive term loan; $30M drawn at close, two $10M tranches available on revenue milestones.","Priced public offering of 35.075M shares at $1.15; gross proceeds $40.3M; net ~$37.5M.","Used $24M of net proceeds to repay Streeterville note ($18.2M) and SVB term loan ($5.8M).","Loan is interest-only for 5 years at SOFR (floor 3%) + 9%; matures Nov 2027; warrants for up to 5M shares at $1.0648.","Management purchased 278,514 shares at $1.15 in a private placement; lock-up 90 days."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-025530","json":"https://secwatch.observer/filing/0000950170-22-025530.json","markdown":"https://secwatch.observer/filing/0000950170-22-025530.md","text":"https://secwatch.observer/filing/0000950170-22-025530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/bdsx-20221116.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T14:56:36.316866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87550b5313024f5880cb427ae968af0eeebd7411","claim":"BIODESIX INC incurred term loan of $30.0 million with Perceptive Credit Holdings IV, LP at greater of forward-looking one-month term SOFR and 3.0% per annum, plus an appli maturing November 21, 2027.","evidence_excerpt":"On November 16, 2022 (the Closing Date), the Company entered into a Credit Agreement and Guaranty (the Credit Agreement) with Perceptive Credit Holdings IV, LP as the lender and administrative agent (the Lender). The Credit Agreement provides for a senior secured delayed draw term loan facility with Perceptive Advisors LLC (Perceptive), in an aggregate principal amount of up to $50.0 million (the Perceptive Term Loan Facility). The initial funding of the Perceptive Term Loan Facility was subject to a capital raise of at least $30.0 million in gross proceeds from an equity offering of the Company's common stock.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"$30.0 million"},{"label":"Counterparty","value":"Perceptive Credit Holdings IV, LP"},{"label":"Rate","value":"greater of forward-looking one-month term SOFR and 3.0% per annum, plus an appli"},{"label":"Maturity","value":"November 21, 2027"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"26e673bc02d7b7965c7ed8f810066cf8a9c19f9e","claim":"BIODESIX INC terminated 2021 Term Loan with Silicon Valley Bank valued at $3 million (effective 2022-11-21).","evidence_excerpt":"and the outstanding principal balance of $3 million under the term loan under the Loan and Security Agreement with Silicon Valley Bank (the 2021 Term Loan)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Silicon Valley Bank"},{"label":"Value","value":"$3 million"},{"label":"Effective","value":"2022-11-21"}],"fact_type":"material_agreement"},{"claim_id":"4dd0d79af1cd774bec670b105fd2c203832e02a0","claim":"BIODESIX INC terminated Promissory Note One with Streeterville Capital, LLC valued at $16.0 million (effective 2022-11-21).","evidence_excerpt":"the Company fully repaid all outstanding principal, accrued and unpaid interest as well as any prepayment and other fees due under the existing $16.0 million promissory note with Streeterville Capital, LLC (Promissory Note One)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Value","value":"$16.0 million"},{"label":"Effective","value":"2022-11-21"}],"fact_type":"material_agreement"},{"claim_id":"6f835e53f25bd11fd3174258200184586709e8d4","claim":"BIODESIX INC entered into Credit Agreement and Guaranty with Perceptive Credit Holdings IV, LP valued at up to $50.0 million (effective 2022-11-16).","evidence_excerpt":"On November 16, 2022 (the Closing Date), the Company entered into a Credit Agreement and Guaranty (the Credit Agreement) with Perceptive Credit Holdings IV, LP as the lender and administrative agent (the Lender).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Perceptive Credit Holdings IV, LP"},{"label":"Value","value":"up to $50.0 million"},{"label":"Effective","value":"2022-11-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}